Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > EVFM Evofem Biosciences > Company Executives
EVFM Evofem Biosciences
0.170
-0.012-6.74%
NamePositionSalaryService DateEducationAgeGenderUpdated
Ms. Saundra PelletierInterim Chairman of the Board, President and Chief Executive Officer3.19M----52female03/30/2022
Mr. Justin J. FileChief Financial Officer and Principal Accounting Officer1.26M----51male03/30/2022
Mr. Alexander A. Fitzpatrick, Esq.General Counsel and Secretary1.05M----55male03/30/2022
Mr. Colin RutherfordIndependent Director158.23K----63male03/30/2022
Dr. Kim P. KamdarIndependent Director159.48K----54female03/30/2022
Dr. Gillian Greer, PhDIndependent Director150.73K----77female03/30/2022
Mr. Tony O’BrienIndependent Director163.23K----59male03/30/2022
Dr. Lisa Dale Rarick, F.A.C.O.G.Independent Director140.35K----62female03/30/2022
Ms. Jenny YipIndependent Director--------female08/03/2022
Company Overview More
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
CEO: Pelletier, Saundra
Market: Pink Market
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top